HIMS 他的討論區(2)

財經台韭菜

985 回覆
5 Like 2 Dislike
SHOWMAKER 2025-02-07 13:31:20
Hims & Hers Health down as Super Bowl ad draws controversy

An advocacy group that includes the main pharmaceutical lobbying organization, PhRMA, as a member is complaining that a commercial Hims & Hers Health (NYSE:HIMS) is slated to run during the Super Bowl about its weight loss offerings violates U.S. FDA advertising regulations and minimizes risks associated with compounded drugs.

On Feb. 5, the Partnership for Safe Medicines sent a letter to Catherine Gray, director of the agency's Office of Prescription Drug Promotion, to voice its concerns.

"The commercial is blatantly misleading, and poses a substantial risk of harming the approximately 200 million consumers that will see the commercial during Super Bowl LIX," the letter signed by PSM Executive Director Shabbir Imber Safdar reads.

Hims & Hers makes a compounded version of semaglutide, the active ingredient in Novo Nordisk's (NVO) blockbuster obesity medicine Wegovy.

While the 60-second ad, titled "Sick of the System," doesn't directly mention compounded semaglutide, the commercial features medicine vials with the company's logo and includes the phrase "There are medications that work, but they are priced for profits, not patients."

The commercial further states that Hims & Hers' offerings are "doctor trusted" and "formulated in the United States."

"The commercial doesn’t just leave out that Hims & Hers’s products are compounded, unapproved, and riskier for patients, it discloses no risks whatsoever," the PSM letter states.

PSM further points to an FDA drug safety communication that states compounded GLP-1 drugs can be risky as they are not FDA approved, and there are dosing and side effects concerns with them.

Compounded versions of brand-name drugs are permitted by the FDA if the medication is in shortage. However, an FDA drug shortages website shows no dose strengths of Wegovy are currently in shortage.

In late October, Wegovy was taken off a drug shortages list.
1664_AMD苦主 2025-02-07 14:00:16
差唔多可以落30
財經台韭菜 2025-02-07 22:47:44
升到我有少少驚
單打不怕多 2025-02-07 22:52:42
Wtf
仍好嗎 2025-02-07 22:55:37
有咩利好會升到咁
Pelinka(佩總) 2025-02-07 23:00:03
To the moon
隱性基因 2025-02-07 23:03:11
Cls我早走左勁多
0098 2025-02-07 23:03:25
ONTO 輸咗
HIMS 贏返
財經台韭菜 2025-02-07 23:30:35
財經台韭菜 2025-02-07 23:36:59
HIMS super bowl 廣告
仍好嗎 2025-02-07 23:48:56
50都唔知賣唔賣好
Pelinka(佩總) 2025-02-08 00:12:26
50應該會放哂等回調
仍好嗎 2025-02-08 00:28:40
開始回調返43附近
C.C. 2025-02-08 10:06:22
樓主會唔會留意下lfmd
korean 2025-02-10 02:15:51
而家應該等咩價位先至買?
無法說明 2025-02-10 10:45:13
睇下 Super Bowl廣告會唔會炒多鑊上去
食蕉啦朋友 2025-02-10 13:09:32
42蚊走晒
0098 2025-02-10 16:06:54
ER 未到就走?
好撚悶呀屌 2025-02-10 17:02:28
如果ER唔係好大beat既話都幾大機會跌返落30中
啲shorts冇少過
Pelinka(佩總) 2025-02-10 17:06:13
跌仲好
想入貨
食蕉啦朋友 2025-02-10 17:38:32
感覺短期上唔到50 等回先再入
食蕉啦朋友 2025-02-10 17:41:33
之前22蚊入
單打不怕多 2025-02-10 17:51:49
呢排癲到好似上年pltr 咁
仍好嗎 2025-02-10 17:53:05
唔睇好佢ER咩?
財經台韭菜 2025-02-10 18:12:47
HIMS我記得經常入Top 10,但HERS以往排20名外,睇嚟super bowl ad幾有效
https://x.com/funofinvesting/status/1888824891303981456?s=46&t=zE7TNOQk4_M-JwTjmVonfA
吹水台自選台熱 門最 新手機台時事台政事台World體育台娛樂台動漫台Apps台遊戲台影視台講故台健康台感情台家庭台潮流台美容台上班台財經台房屋台飲食台旅遊台學術台校園台汽車台音樂台創意台硬件台電器台攝影台玩具台寵物台軟件台活動台電訊台直播台站務台黑 洞